Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
The Food and Drug Administration on Friday approved the first-ever gene-editing therapy that uses a cutting-edge technology called CRISPR to treat sickle cell disease. Dr. Jon LaPook has more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
© 2024 LSD News title="Jegtheme">Jegtheme.